{"id":86991,"date":"2024-12-05T12:16:22","date_gmt":"2024-12-05T10:16:22","guid":{"rendered":"https:\/\/www.noraybio.com\/noraybio-participates-in-the-terminai-project-for-the-optimisation-of-healthcare-data-management-through-artificial-intelligence\/"},"modified":"2025-04-10T13:13:02","modified_gmt":"2025-04-10T11:13:02","slug":"noraybio-participates-in-the-terminai-project-for-the-optimisation-of-healthcare-data-management-through-artificial-intelligence","status":"publish","type":"post","link":"https:\/\/www.noraybio.com\/en\/noraybio-participates-in-the-terminai-project-for-the-optimisation-of-healthcare-data-management-through-artificial-intelligence\/","title":{"rendered":"NorayBio participates in the TerminAI project for the optimisation of healthcare data management through artificial intelligence."},"content":{"rendered":"<h3>NorayBio, BIOLAN, Vicomtech, EProcessMed, Devol, AseBio and Basque Health Cluster join forces to develop a predictive algorithm to optimise healthcare data analysis.<\/h3>\n<p>Basque Health Cluster (BHC), having been certified as an Innovative Business Association (AEI) in December 2023, has been selected to carry out an innovative project in the field of artificial intelligence applied to health within the call of the support programme for innovative business clusters published in June 2024 by the Ministry of Industry and Tourism.<\/p>\n<p>In BHC&#8217;s first call for proposals, the proposed project, TerminAI: Investigating the potential of AI and its ability to optimise the management, coding and harmonisation of health data, has been approved and is among the most outstanding of the call, obtaining the second largest grant in a particularly competitive edition.<\/p>\n<p>This project is being developed by a consortium composed of prestigious companies and organisations: NorayBio, BIOLAN, Vicomtech, EProcessMed, AseBio, the start-up Devol, and BHC itself as leader.<\/p>\n<h4>Project objectives and approach<\/h4>\n<p>The main objective of the <strong>TerminAI project is to improve the efficiency and accuracy of clinical information<\/strong> coding by implementing an <strong>artificial intelligence-assisted system<\/strong>. This system will use advanced natural language processing and machine learning technologies to analyse, understand and contextualise clinical data. The AI will identify patterns, relationships and concepts within the data, mapping them to specific SNOMED CT terms or other standard healthcare data terminologies.  <\/p>\n<p>The project also envisages the application of bioinformatics tools, artificial intelligence and other digital processing and incremental learning technologies in the automated and integrated processing of genetic data that will lead to better diagnosis and prevention of diseases.<\/p>\n<p>In addition to automated coding, TerminAI intends to <strong>digitalise informed consents<\/strong>, which will allow patients to access them more quickly and conveniently, <strong>reducing errors arising from the interpretation<\/strong> of handwriting and improving the quality of the process.<\/p>\n<p>The project will also assess the integration of the coding system with existing health data spaces, ensuring their compatibility and the ability to exchange data securely and efficiently, complying with the requirements set by the European data space.<\/p>\n<h4>Commitment to innovation and improvement in health care<\/h4>\n<p>With this project, Basque Health Cluster reaffirms its <strong>commitment to innovation in the healthcare field<\/strong>, applying cutting-edge technologies to transform clinical data management. TerminAI will enable progress in the quality, efficiency and accuracy of health systems, contributing to more <strong>accessible and safer care<\/strong> for patients. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>NorayBio, BIOLAN, Vicomtech, EProcessMed, Devol, AseBio and Basque Health Cluster  [&#8230;]<\/p>\n","protected":false},"author":2,"featured_media":85971,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[119],"tags":[],"class_list":["post-86991","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noraynews-en-2"],"_links":{"self":[{"href":"https:\/\/www.noraybio.com\/en\/wp-json\/wp\/v2\/posts\/86991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.noraybio.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.noraybio.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.noraybio.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.noraybio.com\/en\/wp-json\/wp\/v2\/comments?post=86991"}],"version-history":[{"count":1,"href":"https:\/\/www.noraybio.com\/en\/wp-json\/wp\/v2\/posts\/86991\/revisions"}],"predecessor-version":[{"id":87032,"href":"https:\/\/www.noraybio.com\/en\/wp-json\/wp\/v2\/posts\/86991\/revisions\/87032"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.noraybio.com\/en\/wp-json\/wp\/v2\/media\/85971"}],"wp:attachment":[{"href":"https:\/\/www.noraybio.com\/en\/wp-json\/wp\/v2\/media?parent=86991"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.noraybio.com\/en\/wp-json\/wp\/v2\/categories?post=86991"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.noraybio.com\/en\/wp-json\/wp\/v2\/tags?post=86991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}